Canadian regulators warn consumers about cardiovascular risks of testosterone drugs
Canada’s national health regulators have issued a warning to consumers and health care providers about the serious risks associated with the use of testosterone-replacement drugs, which are being prescribed to increasing numbers of men as a treatment for low natural
Did Boehringer Ingelheim withhold safety information about blood thinner Pradaxa?
When Pradaxa (dabigatran) hit the market in 2010 to prevent strokes in patients with atrial fibrillation, it became the first alternative treatment to the long-used warfarin for patients with the condition. What made Pradaxa so attractive compared to warfarin (Coumadin)
Experts worry about skyrocketing prescriptions for antidepressants
The number of prescriptions for antidepressants has reached a record high in the United Kingdom, and experts fear that some people may be unnecessarily exposed to antidepressant side effects.
Fresenius faces more than 5,500 NaturaLyte, GranuFlo lawsuits
Fresenius Medical Care, the world’s largest provider of dialysis services and products, is facing more than 5,500 lawsuits alleging the company’s dialysis concentrates caused patients to suffer sudden cardiac arrest.
New meta-analysis raises serious questions about SSRI use during pregnancy
There is not enough research to provide a clear guidance on the risks or benefits of antidepressant use during pregnancy, however there are serious concerns regarding the drugs’ affects on newborns that should be addressed, a new meta-analysis has found.
European advisors recommend approval of new combination type 2 diabetes treatment
An advisory panel for European drug regulators is recommending approval for a new type 2 diabetes drug combining the long-acting insulin degludec with Victoza (liraglutide). The favorable recommendation of Novo Nordisk’s drug Xultophy, previously known as IDegLira, was based on
Risperidone side effects send patients to the emergency room
Adverse effects of antipsychotic medications such as Risperdal (risperidone) send more than 20,000 people in the United States to the emergency room each year, prompting the American Psychiatric Association to issue an advisory to clinicians to carefully evaluate patients before
Acetaminophen as effective as placebo in treating lower back pain
The commonly used painkiller acetaminophen, the same drug in over-the-counter Tylenol, doesn’t relieve lower-back pain any better than a placebo, according to a new study published in the journal The Lancet.
FDA approves oxycodone combination drug that resists abuse
A powerful combination opioid painkiller whose euphoric effects can be rendered inactive if the drug is tampered with has been approved by the Food and Drug Administration (FDA). The drug’s formulation aligns with the agency’s commitment to combat the misuse